The ADA has released new research estimating the total costs of diagnosed diabetes have risen to $245 billion in 2012 from $174 billion in 2007, when the cost was last examined. This figure represents a 41 percent increase over a five year period.
Category: Politics & Business
JDRF reported today that Congress has included a $150 million extension of the Special Diabetes Program (SDP) as part of a year-end package of legislation to avert the "fiscal cliff."
"For the past year, we have led the fight in Congress for renewal of the SDP because we know that this program has contributed to remarkable scientific breakthroughs in managing and treating diabetes, and this timely extension is central to curing T1D,"
When Dr. Mariela Glandt, an endocrinologist, volunteered to treat African refugees in Tel Aviv, she had no idea she would meet a type 1 diabetic like Samuel Agant, 28, from South Sudan. Below, Dr. Glandt shares Samuel’s story of living on the streets of Tel Aviv with type 1 diabetes, without a work permit, without food, and without a constant supply of insulin.
Eli Lilly and Company and Boehringer Ingelheim announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development. Included are Boehringer Ingelheim's two oral diabetes agents—linagliptin and BI10773—as well as Lilly's two basal insulin analogues—LY2605541 and LY2963016—as well as the option to co-develop and co-commercialize Lilly's anti-TGF-beta monoclonal antibody.
BioLineRx, a biopharmaceutical development company based in Israel, announced that research underlying its EDP 10 project for the treatment of type 1 diabetes won the Hebrew University's prestigious Kaye Innovation Award for...
A new report published by Diabetes UK, England’s leading diabetes charity, shows diabetes healthcare in England has drifted into a "state of crisis" with less than half of people with diabetes getting the basic minimum care they need...
Continuous glucose monitoring systems maker DexCom, Inc. and Tandem, the developer of first ever touch-screen insulin pump, announced that they have signed a Development and Commercialization Agreement to integrate a future generation of DexCom's...
Novo Nordisk has decided to establish a type 1 diabetes research and development center in Seattle, Washington.
The unique concept behind the new center is to pursue a translational research approach characterized by combining basic research...
Congress declared that the tomato paste on frozen pizza qualified it as a vegetable.
Amylin Pharmaceuticals and Eli Lilly and Company have agreed to terminate their alliance for type 2 diabetes drug, BYETTA (exenatide), and resolve the outstanding litigation between the companies. As part of the agreement, Amylin will...